• NF 340: Innovative P2Y11 Antagonist for Assay Precision

  2026-07-20

  Explore how the P2Y11 antagonist NF 340 empowers immunology research and inflammation pathway modulation, with deep insights into assay design and translational impact. Discover unique guidance not found in existing NF 340 content.

• MHY1485 (SKU B5853): Reliable mTOR Activation for Autophagy

  2026-07-19

  This article provides a scenario-driven, evidence-based exploration of MHY1485 (SKU B5853) as a potent mTOR activator for cellular assays. Addressing common laboratory challenges in autophagy and cell proliferation studies, it highlights how MHY1485 from APExBIO delivers consistent, data-backed results for advanced research workflows.

• Homoharringtonine in Translational Oncology and Antiviral Re

  2026-07-18

  Explore the unique dual-domain impact of Homoharringtonine, a potent cytotoxic alkaloid, as both a cancer biology tool and a leading candidate for broad-spectrum antiviral research. This article offers deeper mechanistic insights and practical assay guidance beyond existing resources.

• Cardiovascular Outcomes of Ertugliflozin in Type 2 Diabetes:

  2026-07-17

  The VERTIS CV trial rigorously assessed the cardiovascular safety of Ertugliflozin (PF-04971729), a selective SGLT2 inhibitor, in patients with type 2 diabetes and established atherosclerotic cardiovascular disease. The study found that Ertugliflozin was noninferior to placebo for major adverse cardiovascular events, providing critical evidence for its safety profile in this high-risk population.

• Anagliptin (SK-0403): Advanced Workflows for Vascular and Di

  2026-07-17

  Anagliptin (SK-0403) empowers researchers to dissect both DPP-4 inhibition and direct vasorelaxant mechanisms, uniquely bridging metabolic and cardiovascular workflows. Harness recent mechanistic breakthroughs and actionable protocol enhancements to maximize reproducibility and translational insight in diabetes and vascular smooth muscle assays.

• Transmission and Genetics of Carbapenemase in CREC, Guangdon

  2026-07-16

  Chen et al. (2025) provide a comprehensive molecular epidemiology of carbapenem-resistant Enterobacter cloacae (CREC) in eight hospitals across Guangdong, revealing high prevalence and efficient transmission of carbapenemase-encoding genes, particularly blaNDM-1. The study's robust genotyping and plasmid analysis inform future strategies in antimicrobial resistance research and surveillance.

• Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor in Metabo

  2026-07-16

  Sitagliptin phosphate monohydrate empowers metabolic and diabetes researchers to dissect DPP-4-dependent incretin pathways with precision. This article translates cutting-edge reference findings into practical workflows, addressing experimental design, protocol optimization, and troubleshooting for robust, reproducible results.

• Elobixibat Hydrate: Protocols & Precision for IBAT Inhibitio

  2026-07-15

  Elobixibat hydrate is redefining the research landscape for ileal bile acid transporter inhibition, offering unmatched selectivity and translational power in chronic idiopathic constipation and metabolic studies. This guide details experimental workflows, troubleshooting, and advanced applications, ensuring researchers achieve robust and reproducible results with APExBIO’s high-purity compound.

• JHU-083: Advancing Glutaminase Pathway Research in Disease M

  2026-07-15

  JHU-083, a next-generation 6-diazo-5-oxo-L-norleucine precursor, empowers researchers to dissect glutaminase-driven mechanisms in neurological and inflammatory models with unprecedented selectivity and workflow flexibility. Its high solubility, purity, and targeted inhibition profile make it a decisive tool for studies demanding precise manipulation of glutamate metabolism.

• Anagliptin (SK-0403): Applied Workflows for Vascular Researc

  2026-07-14

  Anagliptin (SK-0403) is redefining metabolic and vascular research by enabling precise dissection of DPP-4 inhibition, Kv channel modulation, and SERCA pump regulation in diabetes models. This guide delivers actionable protocols, troubleshooting tips, and insights to harness Anagliptin’s unique mechanistic profile for robust experimental outcomes.

• Masitinib (AB1010): Workflow Guidance for KIT/PDGFR Research

  2026-07-14

  Masitinib (AB1010) is a potent, selective tyrosine kinase inhibitor used for targeted inhibition of KIT, PDGFRα, and PDGFRβ in cancer, mastocytosis, and inflammatory disease research. It is best suited for DMSO-based protocols needing high kinase selectivity and is unsuitable for workflows demanding broad-spectrum inhibition or aqueous/ethanol solubility.

• Nifedipine (BAY-a-1040): Applied Calcium Influx Inhibition W

  2026-07-13

  Nifedipine (BAY-a-1040) enables precise experimental control over calcium influx and iron metabolism in both cardiac and microbiological research models. This guide delivers actionable protocols, advanced troubleshooting, and practical insights derived from recent liver metabolism studies, revealing how APExBIO’s compound supports reproducible, high-impact bench research.

• Graphene Induces Mitochondrial Apoptosis in Melanoma Cells

  2026-07-13

  This study from Xiamen University investigates how graphene films trigger apoptosis and hypoxic stress in melanoma cells via the intrinsic mitochondrial pathway. The findings highlight key molecular changes and suggest graphene as a potential adjunct for melanoma therapy.

• Simvastatin (Zocor): Applied Protocols for Cholesterol & Can

  2026-07-12

  Simvastatin (Zocor) from APExBIO empowers researchers with precise, high-content workflows for both cholesterol-lowering and apoptosis induction in liver cancer models. This article details actionable protocols, advanced troubleshooting, and machine learning-enabled assay optimization to maximize reliability and translational impact.

• Catalpol in Translational Disease Models: Workflow & Trouble

  2026-07-10

  Catalpol empowers researchers to model complex mechanisms in neuroprotection, osteoporosis, and cancer through multi-pathway modulation. This guide delivers actionable workflows, troubleshooting insights, and advanced protocol tuning for maximizing Catalpol’s translational impact in both in vitro and animal studies.

454 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page